Yanwei Xu
- Co-authors
- Hao LiangYan ChengJing HanNing WangJunhui ChenWei ZhengRuosi ChenYanhua Yi
- Topics
- Eicosanoids and Hypertension Pharmacology (4 papers)Peroxisome Proliferator-Activated Receptors (4 papers)Cancer, Hypoxia, and Metabolism (3 papers)
- Cited by
- BiochemistryUrologyNeurology
- Partner nations
- ChinaUnited Arab Emirates
In The Last Decade
Yanwei Xu
23 papers receiving 426 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 199
- Physiology 67
- Plant Science 67
- Cancer Research 51
- Biochemistry 45
Countries citing papers authored by Yanwei Xu
This map shows the geographic impact of Yanwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Xu more than expected).
Fields of papers citing papers by Yanwei Xu
This network shows the impact of papers produced by Yanwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Xu. The network helps show where Yanwei Xu may publish in the future.
Co-authorship network of co-authors of Yanwei Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Yanwei Xu. A scholar is included among the top collaborators of Yanwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwei Xu. Yanwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | 3 | |
| 10 | 15 | |
| 11 | 31 | |
| 12 | 7 | |
| 13 | 68 | |
| 14 | 35 | |
| 15 | 8 | |
| 16 | 72 | |
| 17 | 27 | |
| 18 | 63 | |
| 19 | 38 | |
| 20 | [Inhibit affection of resveratrol on the growth of Hep-2 cell line]. | 1 |
About Yanwei Xu
Yanwei Xu is a scholar working on Biochemistry, Cancer Research and Hepatology, having authored 24 papers that have together received 432 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (4 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Biochemistry (45 citations), Urology (37 citations) and Neurology (36 citations). Yanwei Xu has collaborated with scholars based in China and United Arab Emirates. Frequent co-authors include Hao Liang, Yan Cheng, Jing Han, Jing Han, Ning Wang, Junhui Chen, Wei Zheng, Ruosi Chen, Yanhua Yi and Jin Wang. Their work appears in journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.